Clinical aspects, immunophenotypic analysis and survival rate of chronic lymphocytic leukaemia patients in Erbil city, Iraq

Abstract EN

Objectives: Chronic lymphocytic leukaemia (CLL) is characterised by an accumulation of clonal B cells in the blood, bone marrow and lymphatic tissue.

This study aimed to evaluate the clinical and immunophenotypic characteristics and survival rate of CLL patients.

Methods: This retrospective study was conducted at the Nanakaly Hospital for Blood Diseases & Oncology in Erbil, Iraq, between January 2011 and December 2017.

A total of 105 CLL patients were assessed to determine clinical presentation and staging, immunophenotype and survival rate.

Results: The median age of the patients was 65 years and 63.8% were male.

The main clinical presentations were splenomegaly (64.8%), pallor (61.9%) and lymphadenopathy (60%).

More than half of the patients presented at an advanced clinical stage according to the Rai and Binet staging systems (59.1% and 55.2%, respectively).

All CLL cases expressed both cluster of differentiation (CD)19 and CD5, 67.6% had monoclonal kappa light chains and 21% expressed CD38.

The five-year overall survival (OS) rate was 61.3%.

The mean duration of five-year survival was 41.3 months (95% confidence interval: 36.4–46.3 months).

There were no correlations between survival and sociodemographic, clinical or laboratory characteristics.

Conclusion: In comparison to the existing Western literature, Iraqi CLL patients more frequently presented with hepatosplenomegaly and at a more advanced clinical stage.

In addition, the five-year OS rate was much lower.